Evidence map›Paper›PMID 28532229›Full record

ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2018

Fatigue after a first attack of suspected multiple sclerosis.

Roos M van der Vuurst de Vries, Jan Ja van den Dorpel, Julia Y Mescheriakova, Tessel F Runia, Naghmeh Jafari, Theodora Am Siepman, Dimitris Rizopoulos, Ewout W Steyerberg, Rogier Q Hintzen

Open access · hybridAbstract read
In one paragraph

Article in Multiple sclerosis (Houndmills, Basingstoke, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Regional microglial activation in the substantia nigra is linked with fatigue in MS.Neurology(R) neuroimmunology & neuroinflammation · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Roos M van der Vuurst de VriesMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Jan Ja van den DorpelMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Julia Y MescheriakovaMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Tessel F RuniaMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Naghmeh JafariMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Theodora Am SiepmanMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Dimitris RizopoulosDepartment of Biostatistics, Erasmus MC, Rotterdam, The Netherlands.
Ewout W SteyerbergDepartment of Public Health, Erasmus MC, Rotterdam, The Netherlands.
Rogier Q HintzenMS Centrum ErasMS, Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Erasmus MC · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFatigue is reported by more than 75% of multiple sclerosis (MS) patients. In an earlier study, we showed that fatigue is not only a common symptom in patients at time of clinically isolated syndrome (CIS; fatigued 46%) but also predicts subsequent diagnosis of clinically definite multiple sclerosis (CDMS). The course of fatigue after CIS is unknown.

objectiveWe aimed to explore the long-term course of fatigue after CIS.

methodsIn this study, 235 CIS patients, aged 18-50 years, were prospectively followed. Patients filled in the Krupp's Fatigue Severity Scale (FSS) and the Hospital Anxiety and Depression Scale (HADS) at baseline and annually. After reaching CDMS diagnosis, Expanded Disability Status Scale (EDSS) was obtained annually. Mixed-effects models were used to analyse longitudinal FSS measurements.

resultsFatigue at baseline was an independent predictor for CDMS diagnosis (hazard ratio (HR): 2.6, 95% confidence interval (CI): 1.6-4.4). The evolution of FSS was the same in CIS patients who remained monophasic and patients who were diagnosed with CDMS during follow-up. However, FSS increased by 0.86 units after reaching CDMS diagnosis ( p = 0.01). After this increase, the FSS course remained unaltered ( p = 0.44).

conclusionFatigue, which is often present at time of CIS, probably persists over time and increases after a second attack.

Indexed as

AdultDemyelinating DiseasesDisability EvaluationDisease ProgressionFatigueFemaleHumansLongitudinal StudiesMaleMiddle AgedMultiple SclerosisProspective StudiesCISClinically isolated syndromeearly MSfatiguemultiple sclerosisprognosis

Identifiers

PMID28532229
PMCPMC6027780
OpenAlexW2618178274

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.